ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Rheumatology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,322Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 59

$999K Total Retail Price of All Prescriptions

Rank: 8 out of 59

710 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
22% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 710 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

9% of this provider’s 710 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Risky Drugs to Seniors

1% of this provider’s 13,207 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 3%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$65 was the average price of a prescription from this provider, compared to $117 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
GABAPENTIN 783 654 1 7
HYDROXYCHLOROQUINE SULFATE 661 505 2 4
LEVOTHYROXINE SODIUM 551 534 3 20
SIMVASTATIN 542 482 4 26
TRAMADOL HCL 470 409 5 5
METHOTREXATE 429 335 6 1
PRAVASTATIN SODIUM 378 327 7 45
ALLOPURINOL 369 295 8 8
CITALOPRAM HBR 330 272 9 35
OMEPRAZOLE 329 286 10 16
LOSARTAN-HYDROCHLOROTHIAZIDE 325 295 11 55
FUROSEMIDE 321 315 12 28
PREDNISONE 312 221 13 2
AMLODIPINE BESYLATE 306 258 14 29
SPIRONOLACTONE 271 242 15 60
LOSARTAN POTASSIUM 251 221 16 46
BISOPROLOL-HYDROCHLOROTHIAZIDE 247 226 17 63
TRAMADOL HCL-ACETAMINOPHEN 246 225 18 32
MELOXICAM 244 214 19 6
CARVEDILOL 238 208 20 52
ATORVASTATIN CALCIUM 230 219 21 58
ZOLPIDEM TARTRATE 226 203 22 14
LISINOPRIL 182 138 23 47
METFORMIN HCL 179 158 24 53
POTASSIUM CHLORIDE 151 117 25 42
METHYLPREDNISOLONE 150 122 26 30
CYMBALTA 142 132 27 12
ATENOLOL 135 135 28 72
RANITIDINE HCL 133 107 29 87
HYDROCODONE-ACETAMINOPHEN 132 111 S3 30 3
CLOPIDOGREL 126 109 31 71
WARFARIN SODIUM 124 117 32 73
ENBREL 112 65 33 18
METOPROLOL SUCCINATE 111 111 34 83
METOPROLOL TARTRATE 105 86 35 68
PANTOPRAZOLE SODIUM 102 93 36 85
AZITHROMYCIN 102 92 36 80
LEFLUNOMIDE 101 67 38 11
CRESTOR 98 98 39 76
DIOVAN 97 97 40 101
LYRICA 93 67 41 9
ALENDRONATE SODIUM 91 90 42 17
DIGOXIN 88 88 43 102
PAROXETINE HCL 86 70 44 104
GLIPIZIDE 86 79 44 104
CIPROFLOXACIN HCL 83 78 46 75
TAMSULOSIN HCL 81 81 47 108
PLAVIX 80 75 48 86
NEXIUM 74 57 49 41
KLOR-CON M20 73 60 50 110
TRAZODONE HCL 71 61 51 23
ESCITALOPRAM OXALATE 70 52 52 111
ISOSORBIDE MONONITRATE ER 70 70 52 111
TRIAMTERENE-HCTZ 67 67 54 79
GLIMEPIRIDE 66 60 55 114
FLUTICASONE PROPIONATE 64 57 56 68
VOLTAREN 64 50 56 36
DONEPEZIL HCL 61 61 58 93
ETODOLAC 60 48 59 34
ENALAPRIL MALEATE 55 45 60 96
METOCLOPRAMIDE HCL 53 27 61 123
SYNTHROID 51 45 62 87
RAMIPRIL 50 50 63 127
BENAZEPRIL-HYDROCHLOROTHIAZIDE 50 40 63 127
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 10, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.